Benchling, Inc., a San Francisco, CA-based developer of cloud-based tools for life science, closed $5m in new financing.
The round was led by Andreessen Horowitz with participation from Thrive Capital. Investors also included Y Combinator, Rock Health, FF Angel, SV Angel, Tim Draper, Geoff Ralston, Kevin Mahaffey, and Matt Huang.
The company intends to use the funds to accelerate commercial operations and expand software engineering and global customer support teams.
Led by Sajith Wickramasekara, Chief Executive Officer, Benchling has launched its new platform which aims to accelerate R&D by tracking experiment details, facilitating collaboration, and streamlining data analysis.
The platform features:
– apps for core functions, such as designing DNA, creating interactive protocols, and annotating gel images;
– a live activity stream of research across an organization or lab;
– full-search over experimental data and context; and
– the ability to document, track, and witness experiments as they progress.